FIGURE
Fig. 3
- ID
- ZDB-FIG-231102-18
- Publication
- Zisi et al., 2022 - Small Molecule-mediated Disruption of Ribosome Biogenesis Synergizes With FGFR Inhibitors to Suppress Glioma Cell Growth
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 3
BMH-21 synergizes with TMZ (A) Cell viability of glioma cell lines compared with NHA upon 72 h treatment. (B) Indicated protein levels following 48 h treatment; beta-actin served as a loading control. (C–D) IF-based Quantification of Cleaved Cas3-positive nuclei in (C) serum- and (D) NSC-grown glioma lines (48 h). (E) Cell-cycle distribution barplot of A172 and U18 upon 24 h treatment. (F) Migration assay showing cell-migratory capacity during 6 h-treatment (G) Colony formation assay of H4 and U18 following 72 h-treatment and then 15-day-culture in drug-free media. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Neuro Oncol.